XAMPENSO
Live / Registered — Registered (as of 05 Sept 2023)
What this means for you
Registered since 05 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97528305
- Registration number
- 7156951
- Mark type
- Stylized text
- Filed
- 01 Aug 2022
- Published for opposition
- 20 Jun 2023
- Registered
- 05 Sept 2023
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome
Owner
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
Prosecution history
- 05 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jun 2023 — PUBLISHED FOR OPPOSITION
- 31 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 May 2023 — ASSIGNED TO EXAMINER
- 22 Aug 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Aug 2022 — NEW APPLICATION ENTERED